Cargando…
The Use of MRI and PET Imaging Studies for Prostate Cancer Management: Brief Update, Clinical Recommendations, and Technological Limitations
Multi-parametric magnetic resonance imaging (mpMRI) and positron emission tomography (PET) using prostate-specific membrane antigen (PSMA) targeting ligands have been adopted as a new standard of imaging modality in the management of prostate cancer (PCa). Technological advances with hybrid and adva...
Autores principales: | Mansbridge, Margaret, Chung, Eric, Rhee, Handoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723334/ https://www.ncbi.nlm.nih.gov/pubmed/31387208 http://dx.doi.org/10.3390/medsci7080085 |
Ejemplares similares
-
Imaging tumour thrombus of clear cell renal cell carcinoma: FDG PET or PSMA PET? Direct in vivo comparison of two technologies
por: Saadat, Seyedehpariya, et al.
Publicado: (2017) -
Impact of Physical Exercise Program Interventions on Erectile Function and Cardiovascular Health in Males with Prostate Cancer
por: Chung, Eric, et al.
Publicado: (2022) -
Prostate Cancer—PET Imaging Update
por: Jetty, Sankarsh, et al.
Publicado: (2023) -
A review of the objective cognitive function measurements in males receiving hormonal therapy for prostate cancer
por: Neerhut, Thomas, et al.
Publicado: (2023) -
Cardiac PET/MRI—an update
por: Rischpler, C., et al.
Publicado: (2019)